|
IDENTIFYING SELECTIVE USP16 INHIBITORS TO SUSTAIN STEM CELL PROLIFERATION |
1ZIATR000324-03 |
SIMEONOV, ANTON |
NCATS |
2019 |
|
COMMERCIALIZATION OF A SOFTWARE PLATFORM TO INCREASE THE EFFICIENCY OF HUMAN CLINICAL TRIALS USING PATIENT-LEVEL MACHINE LEARNING MODELS |
5R44TR002047-03 |
ENNIST, DAVID L |
NCATS |
2019 |
|
RAMAN SPECTROSCOPIC STUDIES OF AMYLOIDS |
1ZIAHL006236-02 |
LEE, JENNIFER |
NHLBI |
2019 |
|
THE ROLE OF BRANCHED CHAIN AMINO ACID METABOLISM IN THE REGULATION OF LIFESPAN AND COGNITIVE DECLINE |
1F32AG062036-01A1 |
MOR, DANIELLE EMILLE |
NIA |
2019 |
|
MECHANISMS OF HUMAN SKELETAL MUSCLE MOTOR UNIT REMODELING IN PARKINSON'S DISEASE |
1F32AG062048-01A1 |
LAVIN, KALEEN M |
NIA |
2019 |
|
A MULTI-MODAL IMAGING MODEL TO PREDICT MOBILITY IN OLDER ADULTS |
1K01AG064044-01 |
POOLE, VICTORIA N |
NIA |
2019 |
|
USE OF HIGH DENSITY LIPOPROTEIN PROTEOME IN THE PREDICTION OF COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE: (REGARDS) |
1R01AG061186-01 |
ROSENSON, ROBERT SIDNEY |
NIA |
2019 |
|
HYPERPHOSPHORYLATED TAU AGGREGATION-BASED ALZHEIMER'S DISEASE EARLY DRUG DISCOVERY |
1R01AG062435-01 |
KUO, MIN-HAO |
NIA |
2019 |
|
UNDERSTANDING THE MOLECULAR MECHANISMS THAT CONTRIBUTE TO NEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMER DISEASE |
1R01AG067025-01 |
ROUSSOS, PANAGIOTIS |
NIA |
2019 |
|
DROSOPHILA MODELS FOR TAU TOXICITY AND SPREADING IN THE CENTRAL NERVOUS SYSTEM |
1R03AG063295-01 |
PEARCE, MARGARET MARIE |
NIA |
2019 |